Gliomas arising in the setting of NF1 are driven by biallelic NF1 inactivation: tumors develop following somatic inactivation of the remaining wildtype allele through either the loss of heterozygosity (LOH) or a second tumor-acquired mutation [1,3,35]. Here, NF1 is linked to central nervous system cancer.